Mineralys Therapeutics Target Price

Explore Mineralys Therapeutics's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28.21

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-03-13	JefferiesDennis Ding	$30	6.3% upside
2026-03-10	H.C. WainwrightMatthew Caufield	$56	98.5% upside
2025-12-19	Stifel Nicolaus	$52	84.3% upside
2025-10-30	H.C. Wainwright	$52	84.3% upside
2025-05-14	GuggenheimSeamus Fernandez	$48	70.2% upside
2025-04-02	H.C. WainwrightMatthew Caufield	$42	48.9% upside
2024-04-02	Goldman SachsRichard Law	$30	6.3% upside

Mineralys Therapeutics (MLYS) FAQ

Stockcircle tracks target price for Mineralys Therapeutics (MLYS), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Mineralys Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main MLYS overview so you can move from this figure to the surrounding analysis quickly.